Healthcare Quality and Worker Safety Information
Briggs Healthcare
JANUARY 11, 2024
Given the recent increase in nirsevimab supply and the manufacturers’ plan to release an additional 230,000 doses in January , CDC advises healthcare providers to return to recommendations put forward by CDC and the Advisory Committee on Immunization Practices (ACIP) on use of nirsevimab in young children.
Let's personalize your content